The Patanjali group, owned by yoga guru Baba Ramdev said it has launched clinical trials on humans to find a cure for COVID-19 after receiving regulatory approvals.
Acharya Balkrishna, managing director of Patanjali, was quoted in reports that ‘we are not talking about an immunity booster, we are talking about a cure’.
Ready for a challenge? Click here to take our quiz and show off your knowledge!
The clinical trials have begun in Indore and in Jaipur after Patanjali secured permission last week, reports added.
The decision to diversify into the hunt for a cure for the deadly pandemic is unusual for Patanjali because the rush to develop treatments for COVID-19 has so far been led by Big Pharma.
Large pharmaceutical companies such as Gilead Sciences, Pfizer, Johnson & Johnson, Moderna, Inovio Pharmaceutcials and GlaxoSmithKline, among others, are racing to find a successful vaccine.
Ready for a challenge? Click here to take our quiz and show off your knowledge!
Patanjali, co-founded by yoga guru and entrepreneur Baba Ramdev, runs a sprawling business empire and employs some 50,000 people.